WHO ICTRP trial
Investigating the effect of PRP and GCSF on infertility
IRCT20220813055671N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220813055671N1 |
|---|---|
| Public title | Investigating the effect of PRP and GCSF on infertility |
| Scientific title | A comparative study of the effect of platelet-rich plasma (PRP) and granulocyte colony-stimulating factor (GCSF) in patients with recurrent implantation failure |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | recurrent implantation failure. |
| Interventions | Intervention 1: Intervention group 1 GCSF subcutaneous injection of 300 micrograms once. Intervention 2: Intervention group 2 PRP injection in the amount of 2.5 cc once intrauterine. |
| Registration date | Jan 29, 2023 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: